Product Information
ESOMEPRAZOLE MAG DR 40 MG CAP is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1403 per EA under NDC 68462039190. Its NADAC has been published 158 times since Feb 23, 2022.
FDA first approved this application on May 10, 2019.
Strength
40 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462039190
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
ESOMEPRAZOLE MAGNESIUMApproval Type
Generic (ANDA)
FDA Application
ANDA209495FDA Approved
5/10/2019
On Market Since
11/1/2021
Pharmacological Classes
Price Statistics
The NADAC for ESOMEPRAZOLE MAG DR 40 MG CAP has been published 158 times since Feb 23, 2022, and over the history we have for it it has declined 37.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1403 per EA |
|---|---|
| All-time high | $0.2237 (Mar 16, 2022) |
| All-time low | $0.1104 (Nov 20, 2024) |
| Median price | $0.1671 |
| Average price | $0.1657 |
| Largest weekly change | -28.0% (Nov 20, 2024) |
| Weeks tracked | 158 |
| Tracking since | Feb 23, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-15.9%
5Y
N/A
All
-37.3%
Last surveyed Feb 26, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Esomeprazole Magnesium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ESOMEPRAZOLE MAG DR 40 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for ESOMEPRAZOLE MAG DR 40 MG CAP, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1403 per EA (NDC 68462039190), effective Feb 26, 2025.
How has the price of ESOMEPRAZOLE MAG DR 40 MG CAP changed over time?
Over the history we have for it, the NADAC for ESOMEPRAZOLE MAG DR 40 MG CAP has declined 37.3%. It has been tracked across 158 weekly CMS publications since Feb 23, 2022.
What are the highest and lowest recorded NADAC prices for ESOMEPRAZOLE MAG DR 40 MG CAP?
Since Feb 23, 2022, the NADAC for ESOMEPRAZOLE MAG DR 40 MG CAP has ranged from a low of $0.1104 (Nov 20, 2024) to a high of $0.2237 (Mar 16, 2022), with a median of $0.1671 per EA.
Are there cheaper alternatives to ESOMEPRAZOLE MAG DR 40 MG CAP?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ESOMEPRAZOLE MAG DR 40 MG CAP, is $0.1218 per EA — about 13% below ESOMEPRAZOLE MAG DR 40 MG CAP.
Who manufactures ESOMEPRAZOLE MAG DR 40 MG CAP?
ESOMEPRAZOLE MAG DR 40 MG CAP (NDC 68462039190) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.